What We Know and Don’t Know About l -Arginine and NO
- 9 May 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (18) , 2126-2129
- https://doi.org/10.1161/01.cir.101.18.2126
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The vascular effects of L-Arginine in humans. The role of endogenous insulin.Journal of Clinical Investigation, 1997
- ACE Inhibition, Endothelial Function and Coronary Artery LesionsDrugs, 1997
- Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.Journal of Clinical Investigation, 1996
- Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO productionAtherosclerosis, 1995
- Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteriesThe American Journal of Cardiology, 1992
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Über die Synthese des dl‐Arginins (α‐Amino‐δ‐guanido‐n‐valeriansäure) und der isomeren α‐Guanido‐δ‐amino‐n‐valeriansäureEuropean Journal of Inorganic Chemistry, 1910